nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—ABCB1—hematologic cancer	0.0517	1	CbGaD
Amiodarone—CYP2A6—Methoxsalen—hematologic cancer	0.0175	0.0299	CbGbCtD
Amiodarone—CYP1A2—Anagrelide—hematologic cancer	0.015	0.0255	CbGbCtD
Amiodarone—CYP1A1—Methoxsalen—hematologic cancer	0.015	0.0255	CbGbCtD
Amiodarone—CYP1A1—Bortezomib—hematologic cancer	0.0143	0.0243	CbGbCtD
Amiodarone—CYP1A1—Daunorubicin—hematologic cancer	0.0136	0.0232	CbGbCtD
Amiodarone—CYP2A6—Ifosfamide—hematologic cancer	0.0128	0.0218	CbGbCtD
Amiodarone—CYP1A1—Thalidomide—hematologic cancer	0.0124	0.0212	CbGbCtD
Amiodarone—CYP1A1—Dacarbazine—hematologic cancer	0.0107	0.0182	CbGbCtD
Amiodarone—CYP2C9—Bexarotene—hematologic cancer	0.00936	0.0159	CbGbCtD
Amiodarone—ABCB1—Lenalidomide—hematologic cancer	0.00909	0.0155	CbGbCtD
Amiodarone—CYP3A7—Ifosfamide—hematologic cancer	0.00875	0.0149	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00875	0.0149	CbGbCtD
Amiodarone—CYP2A6—Prednisolone—hematologic cancer	0.00853	0.0145	CbGbCtD
Amiodarone—CYP1A1—Dasatinib—hematologic cancer	0.00839	0.0143	CbGbCtD
Amiodarone—CYP3A7—Imatinib—hematologic cancer	0.00836	0.0142	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00836	0.0142	CbGbCtD
Amiodarone—CYP2C8—Bortezomib—hematologic cancer	0.00823	0.014	CbGbCtD
Amiodarone—CYP3A5—Daunorubicin—hematologic cancer	0.00818	0.0139	CbGbCtD
Amiodarone—CYP2D6—Lomustine—hematologic cancer	0.00796	0.0136	CbGbCtD
Amiodarone—CYP1A2—Carmustine—hematologic cancer	0.00787	0.0134	CbGbCtD
Amiodarone—CYP2C9—Idarubicin—hematologic cancer	0.00776	0.0132	CbGbCtD
Amiodarone—CYP3A5—Thalidomide—hematologic cancer	0.00745	0.0127	CbGbCtD
Amiodarone—CYP3A5—Teniposide—hematologic cancer	0.00711	0.0121	CbGbCtD
Amiodarone—CYP2D6—Idarubicin—hematologic cancer	0.00709	0.0121	CbGbCtD
Amiodarone—CYP2C19—Bortezomib—hematologic cancer	0.0069	0.0118	CbGbCtD
Amiodarone—CYP1A2—Methoxsalen—hematologic cancer	0.0067	0.0114	CbGbCtD
Amiodarone—CYP3A5—Ifosfamide—hematologic cancer	0.00656	0.0112	CbGbCtD
Amiodarone—CYP1A2—Bortezomib—hematologic cancer	0.00637	0.0108	CbGbCtD
Amiodarone—CYP2C8—Ifosfamide—hematologic cancer	0.00631	0.0107	CbGbCtD
Amiodarone—CYP3A5—Imatinib—hematologic cancer	0.00627	0.0107	CbGbCtD
Amiodarone—CYP1A2—Daunorubicin—hematologic cancer	0.00609	0.0104	CbGbCtD
Amiodarone—CYP2D6—Hydroxyurea—hematologic cancer	0.00603	0.0103	CbGbCtD
Amiodarone—CYP2C19—Thalidomide—hematologic cancer	0.00601	0.0102	CbGbCtD
Amiodarone—CYP1A2—Alitretinoin—hematologic cancer	0.00597	0.0102	CbGbCtD
Amiodarone—CYP2C9—Bortezomib—hematologic cancer	0.00574	0.00977	CbGbCtD
Amiodarone—CYP2C19—Teniposide—hematologic cancer	0.00574	0.00977	CbGbCtD
Amiodarone—CYP1A2—Thalidomide—hematologic cancer	0.00555	0.00945	CbGbCtD
Amiodarone—CYP2C8—Nilotinib—hematologic cancer	0.00548	0.00933	CbGbCtD
Amiodarone—CYP3A4—Bexarotene—hematologic cancer	0.00544	0.00927	CbGbCtD
Amiodarone—ABCB1—Daunorubicin—hematologic cancer	0.00533	0.00907	CbGbCtD
Amiodarone—CYP2C19—Ifosfamide—hematologic cancer	0.00529	0.00902	CbGbCtD
Amiodarone—CYP2D6—Bortezomib—hematologic cancer	0.00525	0.00894	CbGbCtD
Amiodarone—CYP3A7—Irinotecan—hematologic cancer	0.00522	0.00889	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00522	0.00889	CbGbCtD
Amiodarone—ABCB1—Alitretinoin—hematologic cancer	0.00522	0.00889	CbGbCtD
Amiodarone—CYP3A4—Busulfan—hematologic cancer	0.00506	0.00862	CbGbCtD
Amiodarone—CYP3A4—Lomustine—hematologic cancer	0.00506	0.00862	CbGbCtD
Amiodarone—CYP2C19—Imatinib—hematologic cancer	0.00506	0.00861	CbGbCtD
Amiodarone—CYP3A5—Dasatinib—hematologic cancer	0.00504	0.00858	CbGbCtD
Amiodarone—CYP2A6—Dexamethasone—hematologic cancer	0.00503	0.00856	CbGbCtD
Amiodarone—CYP2C9—Thalidomide—hematologic cancer	0.005	0.00851	CbGbCtD
Amiodarone—CYP1A2—Dacarbazine—hematologic cancer	0.00477	0.00813	CbGbCtD
Amiodarone—CYP2C9—Teniposide—hematologic cancer	0.00477	0.00812	CbGbCtD
Amiodarone—CYP1A2—Imatinib—hematologic cancer	0.00467	0.00795	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00456	0.00777	CbGbCtD
Amiodarone—CYP3A7—Vincristine—hematologic cancer	0.00456	0.00777	CbGbCtD
Amiodarone—CYP3A4—Thiotepa—hematologic cancer	0.00451	0.00768	CbGbCtD
Amiodarone—CYP2C9—Ifosfamide—hematologic cancer	0.0044	0.0075	CbGbCtD
Amiodarone—CYP1A1—Dexamethasone—hematologic cancer	0.0043	0.00732	CbGbCtD
Amiodarone—CYP2C9—Imatinib—hematologic cancer	0.0042	0.00716	CbGbCtD
Amiodarone—ABCB1—Imatinib—hematologic cancer	0.00408	0.00695	CbGbCtD
Amiodarone—CYP3A5—Irinotecan—hematologic cancer	0.00392	0.00667	CbGbCtD
Amiodarone—CYP2D6—Imatinib—hematologic cancer	0.00384	0.00655	CbGbCtD
Amiodarone—CYP2C9—Nilotinib—hematologic cancer	0.00382	0.00651	CbGbCtD
Amiodarone—CYP1A2—Dasatinib—hematologic cancer	0.00375	0.00638	CbGbCtD
Amiodarone—ABCB1—Nilotinib—hematologic cancer	0.00371	0.00632	CbGbCtD
Amiodarone—ABCB1—Vinorelbine—hematologic cancer	0.00368	0.00626	CbGbCtD
Amiodarone—CYP3A4—Methoxsalen—hematologic cancer	0.00351	0.00597	CbGbCtD
Amiodarone—CYP2D6—Nilotinib—hematologic cancer	0.00349	0.00595	CbGbCtD
Amiodarone—CYP2D6—Vinorelbine—hematologic cancer	0.00346	0.0059	CbGbCtD
Amiodarone—CYP3A7—Dexamethasone—hematologic cancer	0.00344	0.00586	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00344	0.00586	CbGbCtD
Amiodarone—CYP3A5—Vincristine—hematologic cancer	0.00342	0.00583	CbGbCtD
Amiodarone—CYP3A4—Bortezomib—hematologic cancer	0.00334	0.00568	CbGbCtD
Amiodarone—CYP2C19—Prednisone—hematologic cancer	0.00333	0.00567	CbGbCtD
Amiodarone—ABCB1—Dasatinib—hematologic cancer	0.00328	0.00558	CbGbCtD
Amiodarone—ABCB1—Mitoxantrone—hematologic cancer	0.00324	0.00551	CbGbCtD
Amiodarone—CYP3A4—Daunorubicin—hematologic cancer	0.00319	0.00544	CbGbCtD
Amiodarone—CYP3A5—Etoposide—hematologic cancer	0.00314	0.00534	CbGbCtD
Amiodarone—CYP2C8—Etoposide—hematologic cancer	0.00302	0.00514	CbGbCtD
Amiodarone—ABCB1—Betamethasone—hematologic cancer	0.00289	0.00491	CbGbCtD
Amiodarone—ABCB1—Gemcitabine—hematologic cancer	0.00286	0.00487	CbGbCtD
Amiodarone—ABCB1—Prednisolone—hematologic cancer	0.00285	0.00485	CbGbCtD
Amiodarone—CYP3A4—Cytarabine—hematologic cancer	0.00282	0.00479	CbGbCtD
Amiodarone—CYP3A4—Teniposide—hematologic cancer	0.00277	0.00472	CbGbCtD
Amiodarone—ABCB1—Prednisone—hematologic cancer	0.00269	0.00458	CbGbCtD
Amiodarone—CYP3A5—Dexamethasone—hematologic cancer	0.00258	0.00439	CbGbCtD
Amiodarone—CYP3A4—Ifosfamide—hematologic cancer	0.00256	0.00436	CbGbCtD
Amiodarone—ABCB1—Irinotecan—hematologic cancer	0.00255	0.00434	CbGbCtD
Amiodarone—CYP2C8—Dexamethasone—hematologic cancer	0.00248	0.00422	CbGbCtD
Amiodarone—CYP3A4—Imatinib—hematologic cancer	0.00244	0.00416	CbGbCtD
Amiodarone—CYP1A2—Etoposide—hematologic cancer	0.00233	0.00398	CbGbCtD
Amiodarone—Lucanthone—TOP1—hematologic cancer	0.00233	0.652	CrCbGaD
Amiodarone—CYP3A4—Ruxolitinib—hematologic cancer	0.0023	0.00392	CbGbCtD
Amiodarone—ABCB1—Vinblastine—hematologic cancer	0.00227	0.00386	CbGbCtD
Amiodarone—ABCB1—Vincristine—hematologic cancer	0.00223	0.00379	CbGbCtD
Amiodarone—CYP3A4—Nilotinib—hematologic cancer	0.00222	0.00378	CbGbCtD
Amiodarone—CYP3A4—Vinorelbine—hematologic cancer	0.0022	0.00375	CbGbCtD
Amiodarone—CYP2C9—Cisplatin—hematologic cancer	0.00214	0.00365	CbGbCtD
Amiodarone—CYP2D6—Vinblastine—hematologic cancer	0.00214	0.00364	CbGbCtD
Amiodarone—CYP2C19—Dexamethasone—hematologic cancer	0.00208	0.00354	CbGbCtD
Amiodarone—ABCB1—Cisplatin—hematologic cancer	0.00208	0.00354	CbGbCtD
Amiodarone—ABCB1—Etoposide—hematologic cancer	0.00204	0.00348	CbGbCtD
Amiodarone—CYP3A4—Triamcinolone—hematologic cancer	0.00201	0.00343	CbGbCtD
Amiodarone—CYP3A4—Dasatinib—hematologic cancer	0.00196	0.00334	CbGbCtD
Amiodarone—CYP3A4—Mitoxantrone—hematologic cancer	0.00194	0.0033	CbGbCtD
Amiodarone—CYP2C9—Dexamethasone—hematologic cancer	0.00173	0.00295	CbGbCtD
Amiodarone—CYP3A4—Betamethasone—hematologic cancer	0.00173	0.00294	CbGbCtD
Amiodarone—CYP3A4—Prednisolone—hematologic cancer	0.00171	0.00291	CbGbCtD
Amiodarone—ABCB1—Dexamethasone—hematologic cancer	0.00168	0.00286	CbGbCtD
Amiodarone—CYP3A4—Prednisone—hematologic cancer	0.00161	0.00274	CbGbCtD
Amiodarone—CYP2D6—Dexamethasone—hematologic cancer	0.00158	0.00269	CbGbCtD
Amiodarone—CYP3A4—Irinotecan—hematologic cancer	0.00153	0.0026	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—hematologic cancer	0.00139	0.00237	CbGbCtD
Amiodarone—CYP3A4—Vinblastine—hematologic cancer	0.00136	0.00231	CbGbCtD
Amiodarone—ABCB1—Methotrexate—hematologic cancer	0.00135	0.0023	CbGbCtD
Amiodarone—THRA—gonad—hematologic cancer	0.00134	0.0469	CbGeAlD
Amiodarone—THRB—gonad—hematologic cancer	0.00134	0.0469	CbGeAlD
Amiodarone—CYP3A4—Vincristine—hematologic cancer	0.00133	0.00227	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—hematologic cancer	0.00131	0.00223	CbGbCtD
Amiodarone—CYP3A4—Etoposide—hematologic cancer	0.00122	0.00208	CbGbCtD
Amiodarone—CACNA1H—gonad—hematologic cancer	0.00107	0.0377	CbGeAlD
Amiodarone—THRA—lung—hematologic cancer	0.00102	0.0358	CbGeAlD
Amiodarone—THRB—lung—hematologic cancer	0.00102	0.0358	CbGeAlD
Amiodarone—CACNA2D2—lung—hematologic cancer	0.00101	0.0355	CbGeAlD
Amiodarone—CYP3A4—Dexamethasone—hematologic cancer	0.00101	0.00171	CbGbCtD
Amiodarone—Lucanthone—TOP2A—hematologic cancer	0.000976	0.273	CrCbGaD
Amiodarone—THRB—testis—hematologic cancer	0.000965	0.0338	CbGeAlD
Amiodarone—THRA—testis—hematologic cancer	0.000965	0.0338	CbGeAlD
Amiodarone—CACNA2D2—testis—hematologic cancer	0.000955	0.0335	CbGeAlD
Amiodarone—CYP3A4—Doxorubicin—hematologic cancer	0.000834	0.00142	CbGbCtD
Amiodarone—CACNA1H—testis—hematologic cancer	0.000775	0.0271	CbGeAlD
Amiodarone—THRA—lymph node—hematologic cancer	0.0007	0.0245	CbGeAlD
Amiodarone—THRB—lymph node—hematologic cancer	0.0007	0.0245	CbGeAlD
Amiodarone—CACNA2D2—lymph node—hematologic cancer	0.000692	0.0243	CbGeAlD
Amiodarone—CYP2C19—hematopoietic system—hematologic cancer	0.000673	0.0236	CbGeAlD
Amiodarone—KCNH2—hematopoietic system—hematologic cancer	0.000642	0.0225	CbGeAlD
Amiodarone—CYP2A6—lung—hematologic cancer	0.000607	0.0213	CbGeAlD
Amiodarone—CYP2C8—hematopoietic system—hematologic cancer	0.000587	0.0206	CbGeAlD
Amiodarone—CACNA1H—lymph node—hematologic cancer	0.000561	0.0197	CbGeAlD
Amiodarone—CYP1A2—hematopoietic system—hematologic cancer	0.000549	0.0193	CbGeAlD
Amiodarone—CYP1A1—hematopoietic system—hematologic cancer	0.000542	0.019	CbGeAlD
Amiodarone—SIGMAR1—blood—hematologic cancer	0.000534	0.0187	CbGeAlD
Amiodarone—CYP3A5—hematopoietic system—hematologic cancer	0.00053	0.0186	CbGeAlD
Amiodarone—CYP2C9—hematopoietic system—hematologic cancer	0.000522	0.0183	CbGeAlD
Amiodarone—SIGMAR1—bone marrow—hematologic cancer	0.000517	0.0181	CbGeAlD
Amiodarone—ADRB1—lung—hematologic cancer	0.000488	0.0171	CbGeAlD
Amiodarone—SIGMAR1—lung—hematologic cancer	0.000468	0.0164	CbGeAlD
Amiodarone—CYP2C19—blood—hematologic cancer	0.000446	0.0156	CbGeAlD
Amiodarone—SIGMAR1—testis—hematologic cancer	0.000442	0.0155	CbGeAlD
Amiodarone—KCNH2—blood—hematologic cancer	0.000425	0.0149	CbGeAlD
Amiodarone—KCNH2—bone marrow—hematologic cancer	0.000411	0.0144	CbGeAlD
Amiodarone—CYP3A4—hematopoietic system—hematologic cancer	0.000398	0.0139	CbGeAlD
Amiodarone—CYP2D6—hematopoietic system—hematologic cancer	0.000391	0.0137	CbGeAlD
Amiodarone—CYP2C8—blood—hematologic cancer	0.000389	0.0136	CbGeAlD
Amiodarone—EBP—Azacitidine—Pentostatin—hematologic cancer	0.000385	0.192	CbGdCrCtD
Amiodarone—CYP1A2—blood—hematologic cancer	0.000364	0.0128	CbGeAlD
Amiodarone—CYP1A1—blood—hematologic cancer	0.000359	0.0126	CbGeAlD
Amiodarone—KCNH2—testis—hematologic cancer	0.000352	0.0123	CbGeAlD
Amiodarone—CYP3A5—blood—hematologic cancer	0.000351	0.0123	CbGeAlD
Amiodarone—CYP2C9—blood—hematologic cancer	0.000346	0.0121	CbGeAlD
Amiodarone—EBP—Azacitidine—Clofarabine—hematologic cancer	0.000343	0.171	CbGdCrCtD
Amiodarone—EBP—Azacitidine—Nelarabine—hematologic cancer	0.000323	0.16	CbGdCrCtD
Amiodarone—CYP2C8—testis—hematologic cancer	0.000322	0.0113	CbGeAlD
Amiodarone—SIGMAR1—lymph node—hematologic cancer	0.00032	0.0112	CbGeAlD
Amiodarone—CYP1A2—lung—hematologic cancer	0.000319	0.0112	CbGeAlD
Amiodarone—CYP1A1—lung—hematologic cancer	0.000315	0.011	CbGeAlD
Amiodarone—CYP3A5—lung—hematologic cancer	0.000308	0.0108	CbGeAlD
Amiodarone—ABCB1—hematopoietic system—hematologic cancer	0.000281	0.00986	CbGeAlD
Amiodarone—CYP3A4—blood—hematologic cancer	0.000263	0.00923	CbGeAlD
Amiodarone—CYP2D6—blood—hematologic cancer	0.000259	0.00908	CbGeAlD
Amiodarone—KCNH2—lymph node—hematologic cancer	0.000255	0.00893	CbGeAlD
Amiodarone—EBP—Azacitidine—Fludarabine—hematologic cancer	0.000252	0.125	CbGdCrCtD
Amiodarone—EBP—Azacitidine—Gemcitabine—hematologic cancer	0.000238	0.118	CbGdCrCtD
Amiodarone—EBP—Azacitidine—Cytarabine—hematologic cancer	0.000238	0.118	CbGdCrCtD
Amiodarone—EBP—Azacitidine—Cladribine—hematologic cancer	0.000232	0.115	CbGdCrCtD
Amiodarone—CYP1A1—lymph node—hematologic cancer	0.000215	0.00754	CbGeAlD
Amiodarone—CYP2D6—testis—hematologic cancer	0.000214	0.00751	CbGeAlD
Amiodarone—ABCB1—gonad—hematologic cancer	0.000214	0.0075	CbGeAlD
Amiodarone—ABCB1—blood—hematologic cancer	0.000186	0.00654	CbGeAlD
Amiodarone—ABCB1—bone marrow—hematologic cancer	0.00018	0.00632	CbGeAlD
Amiodarone—ABCB1—lung—hematologic cancer	0.000163	0.00573	CbGeAlD
Amiodarone—ABCB1—testis—hematologic cancer	0.000154	0.00541	CbGeAlD
Amiodarone—Dronedarone—ALB—hematologic cancer	0.000138	0.0385	CrCbGaD
Amiodarone—Dronedarone—ABCB1—hematologic cancer	0.000131	0.0367	CrCbGaD
Amiodarone—ABCB1—lymph node—hematologic cancer	0.000112	0.00392	CbGeAlD
Amiodarone—Rash—Gemcitabine—hematologic cancer	1.76e-05	7.34e-05	CcSEcCtD
Amiodarone—Dermatitis—Gemcitabine—hematologic cancer	1.76e-05	7.33e-05	CcSEcCtD
Amiodarone—Hypersensitivity—Etoposide—hematologic cancer	1.75e-05	7.32e-05	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—hematologic cancer	1.75e-05	7.31e-05	CcSEcCtD
Amiodarone—Erythema—Methotrexate—hematologic cancer	1.75e-05	7.29e-05	CcSEcCtD
Amiodarone—Headache—Gemcitabine—hematologic cancer	1.75e-05	7.29e-05	CcSEcCtD
Amiodarone—Nausea—Vincristine—hematologic cancer	1.75e-05	7.28e-05	CcSEcCtD
Amiodarone—Flushing—Epirubicin—hematologic cancer	1.74e-05	7.27e-05	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—hematologic cancer	1.74e-05	7.25e-05	CcSEcCtD
Amiodarone—Hypersensitivity—Prednisolone—hematologic cancer	1.73e-05	7.22e-05	CcSEcCtD
Amiodarone—Dyspepsia—Betamethasone—hematologic cancer	1.72e-05	7.2e-05	CcSEcCtD
Amiodarone—Dyspepsia—Dexamethasone—hematologic cancer	1.72e-05	7.2e-05	CcSEcCtD
Amiodarone—Urticaria—Triamcinolone—hematologic cancer	1.72e-05	7.16e-05	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—hematologic cancer	1.71e-05	7.14e-05	CcSEcCtD
Amiodarone—Asthenia—Etoposide—hematologic cancer	1.71e-05	7.13e-05	CcSEcCtD
Amiodarone—Body temperature increased—Triamcinolone—hematologic cancer	1.71e-05	7.12e-05	CcSEcCtD
Amiodarone—Oedema—Prednisone—hematologic cancer	1.71e-05	7.12e-05	CcSEcCtD
Amiodarone—Anaphylactic shock—Prednisone—hematologic cancer	1.71e-05	7.12e-05	CcSEcCtD
Amiodarone—Decreased appetite—Betamethasone—hematologic cancer	1.7e-05	7.11e-05	CcSEcCtD
Amiodarone—Decreased appetite—Dexamethasone—hematologic cancer	1.7e-05	7.11e-05	CcSEcCtD
Amiodarone—Nausea—Mitoxantrone—hematologic cancer	1.7e-05	7.09e-05	CcSEcCtD
Amiodarone—Nausea—Irinotecan—hematologic cancer	1.7e-05	7.09e-05	CcSEcCtD
Amiodarone—Infection—Prednisone—hematologic cancer	1.7e-05	7.07e-05	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.69e-05	7.06e-05	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.69e-05	7.06e-05	CcSEcCtD
Amiodarone—Back pain—Methotrexate—hematologic cancer	1.69e-05	7.05e-05	CcSEcCtD
Amiodarone—Fatigue—Dexamethasone—hematologic cancer	1.69e-05	7.05e-05	CcSEcCtD
Amiodarone—Fatigue—Betamethasone—hematologic cancer	1.69e-05	7.05e-05	CcSEcCtD
Amiodarone—Pruritus—Etoposide—hematologic cancer	1.68e-05	7.03e-05	CcSEcCtD
Amiodarone—Shock—Prednisone—hematologic cancer	1.68e-05	7.01e-05	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—hematologic cancer	1.68e-05	7e-05	CcSEcCtD
Amiodarone—Pain—Dexamethasone—hematologic cancer	1.68e-05	6.99e-05	CcSEcCtD
Amiodarone—Pain—Betamethasone—hematologic cancer	1.68e-05	6.99e-05	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—hematologic cancer	1.67e-05	6.99e-05	CcSEcCtD
Amiodarone—Tachycardia—Prednisone—hematologic cancer	1.67e-05	6.95e-05	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—hematologic cancer	1.66e-05	6.93e-05	CcSEcCtD
Amiodarone—Skin disorder—Prednisone—hematologic cancer	1.66e-05	6.92e-05	CcSEcCtD
Amiodarone—Nausea—Gemcitabine—hematologic cancer	1.66e-05	6.91e-05	CcSEcCtD
Amiodarone—Vomiting—Cisplatin—hematologic cancer	1.65e-05	6.89e-05	CcSEcCtD
Amiodarone—Hyperhidrosis—Prednisone—hematologic cancer	1.65e-05	6.88e-05	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—hematologic cancer	1.65e-05	6.87e-05	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—hematologic cancer	1.64e-05	6.86e-05	CcSEcCtD
Amiodarone—Rash—Cisplatin—hematologic cancer	1.64e-05	6.84e-05	CcSEcCtD
Amiodarone—Dermatitis—Cisplatin—hematologic cancer	1.64e-05	6.83e-05	CcSEcCtD
Amiodarone—Erythema—Epirubicin—hematologic cancer	1.64e-05	6.82e-05	CcSEcCtD
Amiodarone—Diarrhoea—Etoposide—hematologic cancer	1.63e-05	6.8e-05	CcSEcCtD
Amiodarone—Anorexia—Prednisone—hematologic cancer	1.63e-05	6.79e-05	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—hematologic cancer	1.62e-05	6.77e-05	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—hematologic cancer	1.62e-05	6.76e-05	CcSEcCtD
Amiodarone—Feeling abnormal—Betamethasone—hematologic cancer	1.61e-05	6.74e-05	CcSEcCtD
Amiodarone—Feeling abnormal—Dexamethasone—hematologic cancer	1.61e-05	6.74e-05	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—hematologic cancer	1.61e-05	6.73e-05	CcSEcCtD
Amiodarone—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.6e-05	6.69e-05	CcSEcCtD
Amiodarone—Gastrointestinal pain—Betamethasone—hematologic cancer	1.6e-05	6.69e-05	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—hematologic cancer	1.6e-05	6.68e-05	CcSEcCtD
Amiodarone—Hypersensitivity—Triamcinolone—hematologic cancer	1.59e-05	6.64e-05	CcSEcCtD
Amiodarone—Back pain—Epirubicin—hematologic cancer	1.58e-05	6.6e-05	CcSEcCtD
Amiodarone—Malaise—Methotrexate—hematologic cancer	1.58e-05	6.58e-05	CcSEcCtD
Amiodarone—Dizziness—Etoposide—hematologic cancer	1.57e-05	6.57e-05	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—hematologic cancer	1.57e-05	6.55e-05	CcSEcCtD
Amiodarone—Urticaria—Betamethasone—hematologic cancer	1.56e-05	6.5e-05	CcSEcCtD
Amiodarone—Urticaria—Dexamethasone—hematologic cancer	1.56e-05	6.5e-05	CcSEcCtD
Amiodarone—Dizziness—Prednisolone—hematologic cancer	1.55e-05	6.48e-05	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—hematologic cancer	1.55e-05	6.48e-05	CcSEcCtD
Amiodarone—Asthenia—Triamcinolone—hematologic cancer	1.55e-05	6.47e-05	CcSEcCtD
Amiodarone—Body temperature increased—Betamethasone—hematologic cancer	1.55e-05	6.46e-05	CcSEcCtD
Amiodarone—Abdominal pain—Dexamethasone—hematologic cancer	1.55e-05	6.46e-05	CcSEcCtD
Amiodarone—Abdominal pain—Betamethasone—hematologic cancer	1.55e-05	6.46e-05	CcSEcCtD
Amiodarone—Body temperature increased—Dexamethasone—hematologic cancer	1.55e-05	6.46e-05	CcSEcCtD
Amiodarone—Nausea—Cisplatin—hematologic cancer	1.54e-05	6.44e-05	CcSEcCtD
Amiodarone—Insomnia—Prednisone—hematologic cancer	1.54e-05	6.44e-05	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—hematologic cancer	1.54e-05	6.43e-05	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—hematologic cancer	1.54e-05	6.41e-05	CcSEcCtD
Amiodarone—Paraesthesia—Prednisone—hematologic cancer	1.53e-05	6.39e-05	CcSEcCtD
Amiodarone—Pruritus—Triamcinolone—hematologic cancer	1.53e-05	6.38e-05	CcSEcCtD
Amiodarone—Cough—Methotrexate—hematologic cancer	1.52e-05	6.36e-05	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—hematologic cancer	1.52e-05	6.33e-05	CcSEcCtD
Amiodarone—Vomiting—Etoposide—hematologic cancer	1.51e-05	6.32e-05	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—hematologic cancer	1.51e-05	6.31e-05	CcSEcCtD
Amiodarone—Agitation—Epirubicin—hematologic cancer	1.5e-05	6.27e-05	CcSEcCtD
Amiodarone—Dyspepsia—Prednisone—hematologic cancer	1.5e-05	6.27e-05	CcSEcCtD
Amiodarone—Rash—Etoposide—hematologic cancer	1.5e-05	6.26e-05	CcSEcCtD
Amiodarone—Dermatitis—Etoposide—hematologic cancer	1.5e-05	6.26e-05	CcSEcCtD
Amiodarone—Headache—Etoposide—hematologic cancer	1.49e-05	6.22e-05	CcSEcCtD
Amiodarone—Decreased appetite—Prednisone—hematologic cancer	1.48e-05	6.19e-05	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—hematologic cancer	1.48e-05	6.18e-05	CcSEcCtD
Amiodarone—Rash—Prednisolone—hematologic cancer	1.48e-05	6.18e-05	CcSEcCtD
Amiodarone—Dermatitis—Prednisolone—hematologic cancer	1.48e-05	6.17e-05	CcSEcCtD
Amiodarone—Malaise—Epirubicin—hematologic cancer	1.47e-05	6.15e-05	CcSEcCtD
Amiodarone—Fatigue—Prednisone—hematologic cancer	1.47e-05	6.14e-05	CcSEcCtD
Amiodarone—Headache—Prednisolone—hematologic cancer	1.47e-05	6.14e-05	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—hematologic cancer	1.47e-05	6.13e-05	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—hematologic cancer	1.47e-05	6.13e-05	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—hematologic cancer	1.46e-05	6.11e-05	CcSEcCtD
Amiodarone—Constipation—Prednisone—hematologic cancer	1.46e-05	6.09e-05	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—hematologic cancer	1.44e-05	6e-05	CcSEcCtD
Amiodarone—Dizziness—Triamcinolone—hematologic cancer	1.43e-05	5.96e-05	CcSEcCtD
Amiodarone—Cough—Epirubicin—hematologic cancer	1.43e-05	5.95e-05	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—hematologic cancer	1.43e-05	5.95e-05	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—hematologic cancer	1.43e-05	5.95e-05	CcSEcCtD
Amiodarone—Infection—Methotrexate—hematologic cancer	1.42e-05	5.91e-05	CcSEcCtD
Amiodarone—Nausea—Etoposide—hematologic cancer	1.41e-05	5.9e-05	CcSEcCtD
Amiodarone—Feeling abnormal—Prednisone—hematologic cancer	1.41e-05	5.87e-05	CcSEcCtD
Amiodarone—Asthenia—Dexamethasone—hematologic cancer	1.41e-05	5.87e-05	CcSEcCtD
Amiodarone—Asthenia—Betamethasone—hematologic cancer	1.41e-05	5.87e-05	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—hematologic cancer	1.4e-05	5.86e-05	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—hematologic cancer	1.4e-05	5.83e-05	CcSEcCtD
Amiodarone—Gastrointestinal pain—Prednisone—hematologic cancer	1.4e-05	5.82e-05	CcSEcCtD
Amiodarone—Nausea—Prednisolone—hematologic cancer	1.39e-05	5.82e-05	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—hematologic cancer	1.39e-05	5.8e-05	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—hematologic cancer	1.39e-05	5.79e-05	CcSEcCtD
Amiodarone—Pruritus—Betamethasone—hematologic cancer	1.39e-05	5.78e-05	CcSEcCtD
Amiodarone—Pruritus—Dexamethasone—hematologic cancer	1.39e-05	5.78e-05	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—hematologic cancer	1.39e-05	5.78e-05	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—hematologic cancer	1.38e-05	5.75e-05	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—hematologic cancer	1.38e-05	5.74e-05	CcSEcCtD
Amiodarone—Vomiting—Triamcinolone—hematologic cancer	1.37e-05	5.73e-05	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—hematologic cancer	1.36e-05	5.69e-05	CcSEcCtD
Amiodarone—Rash—Triamcinolone—hematologic cancer	1.36e-05	5.68e-05	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—hematologic cancer	1.36e-05	5.68e-05	CcSEcCtD
Amiodarone—Dermatitis—Triamcinolone—hematologic cancer	1.36e-05	5.68e-05	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—hematologic cancer	1.36e-05	5.67e-05	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—hematologic cancer	1.36e-05	5.67e-05	CcSEcCtD
Amiodarone—Urticaria—Prednisone—hematologic cancer	1.36e-05	5.66e-05	CcSEcCtD
Amiodarone—Headache—Triamcinolone—hematologic cancer	1.35e-05	5.64e-05	CcSEcCtD
Amiodarone—Abdominal pain—Prednisone—hematologic cancer	1.35e-05	5.63e-05	CcSEcCtD
Amiodarone—Body temperature increased—Prednisone—hematologic cancer	1.35e-05	5.63e-05	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—hematologic cancer	1.35e-05	5.62e-05	CcSEcCtD
Amiodarone—Diarrhoea—Dexamethasone—hematologic cancer	1.34e-05	5.59e-05	CcSEcCtD
Amiodarone—Diarrhoea—Betamethasone—hematologic cancer	1.34e-05	5.59e-05	CcSEcCtD
Amiodarone—Oedema—Epirubicin—hematologic cancer	1.33e-05	5.57e-05	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—hematologic cancer	1.33e-05	5.57e-05	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—hematologic cancer	1.33e-05	5.56e-05	CcSEcCtD
Amiodarone—Infection—Epirubicin—hematologic cancer	1.33e-05	5.53e-05	CcSEcCtD
Amiodarone—Cough—Doxorubicin—hematologic cancer	1.32e-05	5.51e-05	CcSEcCtD
Amiodarone—Shock—Epirubicin—hematologic cancer	1.31e-05	5.48e-05	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—hematologic cancer	1.31e-05	5.45e-05	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—hematologic cancer	1.3e-05	5.44e-05	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—hematologic cancer	1.3e-05	5.41e-05	CcSEcCtD
Amiodarone—Dizziness—Dexamethasone—hematologic cancer	1.3e-05	5.41e-05	CcSEcCtD
Amiodarone—Dizziness—Betamethasone—hematologic cancer	1.3e-05	5.41e-05	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—hematologic cancer	1.29e-05	5.38e-05	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—hematologic cancer	1.29e-05	5.38e-05	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—hematologic cancer	1.28e-05	5.36e-05	CcSEcCtD
Amiodarone—Nausea—Triamcinolone—hematologic cancer	1.28e-05	5.35e-05	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—hematologic cancer	1.28e-05	5.34e-05	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—hematologic cancer	1.27e-05	5.31e-05	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—hematologic cancer	1.27e-05	5.31e-05	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—hematologic cancer	1.27e-05	5.31e-05	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—hematologic cancer	1.26e-05	5.26e-05	CcSEcCtD
Amiodarone—Hypersensitivity—Prednisone—hematologic cancer	1.26e-05	5.25e-05	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—hematologic cancer	1.26e-05	5.24e-05	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—hematologic cancer	1.25e-05	5.2e-05	CcSEcCtD
Amiodarone—Vomiting—Betamethasone—hematologic cancer	1.25e-05	5.2e-05	CcSEcCtD
Amiodarone—Vomiting—Dexamethasone—hematologic cancer	1.25e-05	5.2e-05	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—hematologic cancer	1.24e-05	5.2e-05	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—hematologic cancer	1.24e-05	5.17e-05	CcSEcCtD
Amiodarone—Rash—Betamethasone—hematologic cancer	1.24e-05	5.16e-05	CcSEcCtD
Amiodarone—Rash—Dexamethasone—hematologic cancer	1.24e-05	5.16e-05	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—hematologic cancer	1.23e-05	5.15e-05	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—hematologic cancer	1.23e-05	5.15e-05	CcSEcCtD
Amiodarone—Dermatitis—Betamethasone—hematologic cancer	1.23e-05	5.15e-05	CcSEcCtD
Amiodarone—Dermatitis—Dexamethasone—hematologic cancer	1.23e-05	5.15e-05	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.23e-05	5.14e-05	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—hematologic cancer	1.23e-05	5.13e-05	CcSEcCtD
Amiodarone—Headache—Dexamethasone—hematologic cancer	1.23e-05	5.12e-05	CcSEcCtD
Amiodarone—Headache—Betamethasone—hematologic cancer	1.23e-05	5.12e-05	CcSEcCtD
Amiodarone—Infection—Doxorubicin—hematologic cancer	1.23e-05	5.12e-05	CcSEcCtD
Amiodarone—Asthenia—Prednisone—hematologic cancer	1.22e-05	5.11e-05	CcSEcCtD
Amiodarone—Pain—Methotrexate—hematologic cancer	1.22e-05	5.09e-05	CcSEcCtD
Amiodarone—Shock—Doxorubicin—hematologic cancer	1.21e-05	5.07e-05	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—hematologic cancer	1.21e-05	5.05e-05	CcSEcCtD
Amiodarone—Pruritus—Prednisone—hematologic cancer	1.21e-05	5.04e-05	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—hematologic cancer	1.21e-05	5.04e-05	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—hematologic cancer	1.21e-05	5.03e-05	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—hematologic cancer	1.2e-05	5e-05	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—hematologic cancer	1.2e-05	5e-05	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—hematologic cancer	1.19e-05	4.98e-05	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—hematologic cancer	1.19e-05	4.96e-05	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—hematologic cancer	1.18e-05	4.91e-05	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—hematologic cancer	1.18e-05	4.9e-05	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—hematologic cancer	1.17e-05	4.9e-05	CcSEcCtD
Amiodarone—Diarrhoea—Prednisone—hematologic cancer	1.17e-05	4.87e-05	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—hematologic cancer	1.17e-05	4.87e-05	CcSEcCtD
Amiodarone—Nausea—Betamethasone—hematologic cancer	1.16e-05	4.86e-05	CcSEcCtD
Amiodarone—Nausea—Dexamethasone—hematologic cancer	1.16e-05	4.86e-05	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—hematologic cancer	1.16e-05	4.84e-05	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—hematologic cancer	1.15e-05	4.81e-05	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.15e-05	4.81e-05	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—hematologic cancer	1.15e-05	4.8e-05	CcSEcCtD
Amiodarone—Pain—Epirubicin—hematologic cancer	1.14e-05	4.76e-05	CcSEcCtD
Amiodarone—Constipation—Epirubicin—hematologic cancer	1.14e-05	4.76e-05	CcSEcCtD
Amiodarone—Urticaria—Methotrexate—hematologic cancer	1.13e-05	4.73e-05	CcSEcCtD
Amiodarone—Dizziness—Prednisone—hematologic cancer	1.13e-05	4.71e-05	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—hematologic cancer	1.13e-05	4.7e-05	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—hematologic cancer	1.13e-05	4.7e-05	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—hematologic cancer	1.12e-05	4.66e-05	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—hematologic cancer	1.11e-05	4.63e-05	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—hematologic cancer	1.1e-05	4.59e-05	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—hematologic cancer	1.1e-05	4.59e-05	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.09e-05	4.55e-05	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—hematologic cancer	1.09e-05	4.54e-05	CcSEcCtD
Amiodarone—Vomiting—Prednisone—hematologic cancer	1.08e-05	4.53e-05	CcSEcCtD
Amiodarone—Rash—Prednisone—hematologic cancer	1.08e-05	4.49e-05	CcSEcCtD
Amiodarone—Dermatitis—Prednisone—hematologic cancer	1.07e-05	4.49e-05	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—hematologic cancer	1.07e-05	4.48e-05	CcSEcCtD
Amiodarone—Headache—Prednisone—hematologic cancer	1.07e-05	4.46e-05	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.07e-05	4.45e-05	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—hematologic cancer	1.06e-05	4.44e-05	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—hematologic cancer	1.06e-05	4.42e-05	CcSEcCtD
Amiodarone—Pain—Doxorubicin—hematologic cancer	1.06e-05	4.41e-05	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—hematologic cancer	1.06e-05	4.41e-05	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—hematologic cancer	1.05e-05	4.4e-05	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—hematologic cancer	1.05e-05	4.4e-05	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—hematologic cancer	1.05e-05	4.38e-05	CcSEcCtD
Amiodarone—Asthenia—Methotrexate—hematologic cancer	1.02e-05	4.27e-05	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—hematologic cancer	1.02e-05	4.25e-05	CcSEcCtD
Amiodarone—Nausea—Prednisone—hematologic cancer	1.01e-05	4.23e-05	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.01e-05	4.21e-05	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—hematologic cancer	1.01e-05	4.21e-05	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—hematologic cancer	9.83e-06	4.1e-05	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—hematologic cancer	9.81e-06	4.09e-05	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—hematologic cancer	9.76e-06	4.07e-05	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—hematologic cancer	9.76e-06	4.07e-05	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—hematologic cancer	9.76e-06	4.07e-05	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—hematologic cancer	9.57e-06	4e-05	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—hematologic cancer	9.44e-06	3.94e-05	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—hematologic cancer	9.43e-06	3.94e-05	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—hematologic cancer	9.13e-06	3.81e-05	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—hematologic cancer	9.1e-06	3.8e-05	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—hematologic cancer	9.07e-06	3.78e-05	CcSEcCtD
Amiodarone—Rash—Methotrexate—hematologic cancer	8.99e-06	3.75e-05	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—hematologic cancer	8.98e-06	3.75e-05	CcSEcCtD
Amiodarone—Headache—Methotrexate—hematologic cancer	8.93e-06	3.73e-05	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—hematologic cancer	8.86e-06	3.7e-05	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—hematologic cancer	8.82e-06	3.68e-05	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—hematologic cancer	8.74e-06	3.65e-05	CcSEcCtD
Amiodarone—Vomiting—Epirubicin—hematologic cancer	8.48e-06	3.54e-05	CcSEcCtD
Amiodarone—Nausea—Methotrexate—hematologic cancer	8.47e-06	3.53e-05	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—hematologic cancer	8.45e-06	3.53e-05	CcSEcCtD
Amiodarone—Rash—Epirubicin—hematologic cancer	8.41e-06	3.51e-05	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—hematologic cancer	8.41e-06	3.51e-05	CcSEcCtD
Amiodarone—Headache—Epirubicin—hematologic cancer	8.36e-06	3.49e-05	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—hematologic cancer	8.16e-06	3.41e-05	CcSEcCtD
Amiodarone—Nausea—Epirubicin—hematologic cancer	7.93e-06	3.31e-05	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—hematologic cancer	7.85e-06	3.28e-05	CcSEcCtD
Amiodarone—Rash—Doxorubicin—hematologic cancer	7.79e-06	3.25e-05	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—hematologic cancer	7.78e-06	3.25e-05	CcSEcCtD
Amiodarone—Headache—Doxorubicin—hematologic cancer	7.74e-06	3.23e-05	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—hematologic cancer	7.33e-06	3.06e-05	CcSEcCtD
Amiodarone—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.8e-06	3.2e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FN1—hematologic cancer	2.79e-06	3.19e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CG—hematologic cancer	2.79e-06	3.19e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.79e-06	3.19e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.79e-06	3.19e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TXN—hematologic cancer	2.79e-06	3.19e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYCS—hematologic cancer	2.76e-06	3.16e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.76e-06	3.16e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	2.76e-06	3.16e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—BAD—hematologic cancer	2.76e-06	3.16e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NQO1—hematologic cancer	2.75e-06	3.15e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CD44—hematologic cancer	2.75e-06	3.15e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.75e-06	3.14e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SDC1—hematologic cancer	2.74e-06	3.14e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	2.73e-06	3.13e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.73e-06	3.13e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NQO1—hematologic cancer	2.73e-06	3.12e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CD44—hematologic cancer	2.73e-06	3.12e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.71e-06	3.09e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CD—hematologic cancer	2.68e-06	3.06e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CD80—hematologic cancer	2.68e-06	3.06e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KIT—hematologic cancer	2.67e-06	3.06e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	2.67e-06	3.06e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	2.67e-06	3.06e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.67e-06	3.06e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.65e-06	3.03e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ALB—hematologic cancer	2.64e-06	3.02e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	2.63e-06	3e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.63e-06	3e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.62e-06	3e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.62e-06	3e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYCS—hematologic cancer	2.6e-06	2.98e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CREBBP—hematologic cancer	2.59e-06	2.96e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.59e-06	2.96e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.59e-06	2.96e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYCS—hematologic cancer	2.58e-06	2.95e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.57e-06	2.94e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.57e-06	2.94e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.57e-06	2.93e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	2.56e-06	2.93e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.55e-06	2.92e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.55e-06	2.92e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CREB1—hematologic cancer	2.55e-06	2.91e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.53e-06	2.9e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3R1—hematologic cancer	2.53e-06	2.89e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—BRAF—hematologic cancer	2.51e-06	2.87e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.5e-06	2.85e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCL2—hematologic cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6R—hematologic cancer	2.48e-06	2.84e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	2.48e-06	2.83e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—MTHFR—hematologic cancer	2.48e-06	2.83e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.47e-06	2.83e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CD—hematologic cancer	2.46e-06	2.81e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTP1—hematologic cancer	2.44e-06	2.79e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ALB—hematologic cancer	2.42e-06	2.77e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.41e-06	2.76e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NUP98—hematologic cancer	2.41e-06	2.76e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	2.37e-06	2.71e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.36e-06	2.7e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	2.35e-06	2.69e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.34e-06	2.68e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.34e-06	2.68e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.34e-06	2.67e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NQO1—hematologic cancer	2.33e-06	2.67e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CD44—hematologic cancer	2.33e-06	2.67e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.33e-06	2.66e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NUP214—hematologic cancer	2.32e-06	2.66e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3R1—hematologic cancer	2.32e-06	2.65e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.31e-06	2.64e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	2.3e-06	2.63e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.3e-06	2.63e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.29e-06	2.62e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.29e-06	2.62e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.28e-06	2.61e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.28e-06	2.6e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MTR—hematologic cancer	2.28e-06	2.6e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.28e-06	2.6e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.27e-06	2.6e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGF2—hematologic cancer	2.25e-06	2.57e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NCOR1—hematologic cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTM1—hematologic cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ENO2—hematologic cancer	2.23e-06	2.55e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	2.22e-06	2.54e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYCS—hematologic cancer	2.21e-06	2.52e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.2e-06	2.52e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.2e-06	2.52e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.19e-06	2.51e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.18e-06	2.5e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.17e-06	2.49e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.17e-06	2.48e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—JAK2—hematologic cancer	2.16e-06	2.47e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.15e-06	2.46e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CB—hematologic cancer	2.14e-06	2.45e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SDC1—hematologic cancer	2.12e-06	2.42e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	2.11e-06	2.42e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.11e-06	2.41e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.11e-06	2.41e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MDM2—hematologic cancer	2.11e-06	2.41e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.09e-06	2.39e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.09e-06	2.39e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CG—hematologic cancer	2.08e-06	2.38e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MTOR—hematologic cancer	2.05e-06	2.34e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	2.05e-06	2.34e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.04e-06	2.34e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.03e-06	2.32e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—hematologic cancer	2.02e-06	2.31e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2e-06	2.29e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—MTHFR—hematologic cancer	1.98e-06	2.26e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.97e-06	2.26e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	1.96e-06	2.24e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.94e-06	2.22e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.94e-06	2.21e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CREBBP—hematologic cancer	1.93e-06	2.21e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—EP300—hematologic cancer	1.92e-06	2.2e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	1.92e-06	2.2e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALB—hematologic cancer	1.91e-06	2.19e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.91e-06	2.18e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	1.9e-06	2.17e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—hematologic cancer	1.88e-06	2.15e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.88e-06	2.15e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—hematologic cancer	1.88e-06	2.15e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—hematologic cancer	1.87e-06	2.14e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.86e-06	2.13e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—hematologic cancer	1.85e-06	2.12e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.85e-06	2.11e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.84e-06	2.11e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—hematologic cancer	1.83e-06	2.1e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—JUN—hematologic cancer	1.83e-06	2.09e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CD—hematologic cancer	1.83e-06	2.09e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.83e-06	2.09e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALB—hematologic cancer	1.81e-06	2.07e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CD44—hematologic cancer	1.8e-06	2.06e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NQO1—hematologic cancer	1.8e-06	2.06e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.79e-06	2.04e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.79e-06	2.04e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.79e-06	2.04e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	1.77e-06	2.03e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—hematologic cancer	1.77e-06	2.02e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.77e-06	2.02e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—EP300—hematologic cancer	1.76e-06	2.02e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	1.73e-06	1.98e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3R1—hematologic cancer	1.73e-06	1.98e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	1.73e-06	1.98e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.7e-06	1.95e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYCS—hematologic cancer	1.7e-06	1.95e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.69e-06	1.93e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EP300—hematologic cancer	1.69e-06	1.93e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.69e-06	1.93e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.68e-06	1.92e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.66e-06	1.9e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALB—hematologic cancer	1.66e-06	1.89e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SRC—hematologic cancer	1.64e-06	1.88e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.63e-06	1.86e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	1.6e-06	1.83e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.59e-06	1.82e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.58e-06	1.81e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—hematologic cancer	1.58e-06	1.81e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NRAS—hematologic cancer	1.58e-06	1.81e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.58e-06	1.81e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.58e-06	1.81e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.57e-06	1.79e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.55e-06	1.78e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CREBBP—hematologic cancer	1.54e-06	1.76e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	1.51e-06	1.73e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.5e-06	1.72e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.5e-06	1.71e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALB—hematologic cancer	1.48e-06	1.69e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—hematologic cancer	1.47e-06	1.68e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	1.47e-06	1.68e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.46e-06	1.67e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.46e-06	1.67e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—hematologic cancer	1.46e-06	1.67e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.45e-06	1.66e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALB—hematologic cancer	1.44e-06	1.65e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.44e-06	1.65e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.42e-06	1.63e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.42e-06	1.62e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.41e-06	1.62e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.39e-06	1.59e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—EP300—hematologic cancer	1.39e-06	1.59e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—hematologic cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.38e-06	1.57e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.37e-06	1.56e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—hematologic cancer	1.36e-06	1.55e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALB—hematologic cancer	1.36e-06	1.55e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALB—hematologic cancer	1.35e-06	1.54e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.33e-06	1.52e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—EP300—hematologic cancer	1.31e-06	1.5e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.3e-06	1.49e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.3e-06	1.49e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.3e-06	1.49e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.29e-06	1.47e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—hematologic cancer	1.26e-06	1.44e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	1.25e-06	1.43e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.23e-06	1.41e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.22e-06	1.39e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—hematologic cancer	1.21e-06	1.38e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—EP300—hematologic cancer	1.2e-06	1.38e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.2e-06	1.37e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.19e-06	1.36e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.17e-06	1.33e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—hematologic cancer	1.16e-06	1.33e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—hematologic cancer	1.16e-06	1.32e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALB—hematologic cancer	1.15e-06	1.32e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—hematologic cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—hematologic cancer	1.11e-06	1.26e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.1e-06	1.26e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—hematologic cancer	1.1e-06	1.26e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—EP300—hematologic cancer	1.08e-06	1.23e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—hematologic cancer	1.07e-06	1.22e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—EP300—hematologic cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.03e-06	1.18e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—hematologic cancer	1.03e-06	1.18e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.02e-06	1.17e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—hematologic cancer	1.02e-06	1.17e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.02e-06	1.16e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—EP300—hematologic cancer	9.89e-07	1.13e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—EP300—hematologic cancer	9.81e-07	1.12e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—hematologic cancer	9.72e-07	1.11e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.5e-07	1.09e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9e-07	1.03e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	8.91e-07	1.02e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALB—hematologic cancer	8.89e-07	1.02e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—hematologic cancer	8.79e-07	1e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.5e-07	9.72e-06	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—hematologic cancer	8.41e-07	9.61e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—EP300—hematologic cancer	8.38e-07	9.58e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—hematologic cancer	7.96e-07	9.1e-06	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—hematologic cancer	7.94e-07	9.08e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.85e-07	8.97e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.76e-07	8.88e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.32e-07	8.37e-06	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—hematologic cancer	7.28e-07	8.33e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.25e-07	8.3e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—hematologic cancer	6.78e-07	7.75e-06	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—hematologic cancer	6.5e-07	7.43e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—EP300—hematologic cancer	6.47e-07	7.4e-06	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—hematologic cancer	6.34e-07	7.25e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—hematologic cancer	6.2e-07	7.09e-06	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—hematologic cancer	5.98e-07	6.84e-06	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—hematologic cancer	5.93e-07	6.78e-06	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—hematologic cancer	5.06e-07	5.79e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.78e-07	5.47e-06	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—hematologic cancer	3.91e-07	4.47e-06	CbGpPWpGaD
